Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Lung Cancer Detection in High-Risk Patients With Risk-Based Machine Learning Models and Biomarkers

NCT07848815 is registered in ClinicalTrials.gov with Vejle Hospital as lead sponsor.

NCT NCT07848815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07848815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Lung Cancer Detection in High-Risk Patients With Risk-Based Machine Learning Models and Biomarkers
Lead sponsor
Vejle Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2026
Completion date
December 31, 2033
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd (chronic obstructive pulmonary disease), lung cancer (diagnosis)